Currently out of the existing stock ratings of Bradley Canino, 161 are a BUY (80.9%), 38 are a HOLD (19.1%).

Bradley Canino

Work Performance Price Targets & Ratings Chart

Analyst Bradley Canino, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 37.15% that have a potential upside of 47.68% achieved within 167 days. Previously, Bradley Canino worked at CREDIT SUISSE, STIFEL.

Bradley Canino’s has documented 369 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Energy sectors.

Most recent stock forecast was given on ORIC, Oric Pharmaceuticals  at 12-Jun-2026.

Wall Street Analyst Bradley Canino

Analyst best performing recommendations are on GLTO (GALECTO ).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $25 was fulfilled within 3 days with a profit of $5.86 (30.62%) receiving and performance score of 102.06.

Average potential price target upside

ALXO Alx Oncology Holdings  ARVN Arvinas BPMC Blueprint Medicines Corp CCCC C4 Therapeutics  DCPH Deciphera Pharmaceuticals LLC TPTX Turning Point Therapeutics ZNTL Zentalis Pharmaceuticals Llc BDTX Black Diamond Therapeutics KYMR Kymera Therapeutics AFMD Affimed NV MRUS Merus BV RLAY Relay Therapeutics  KURA Kura Oncology SNDX Syndax Pharmaceuticals THRX Theseus Pharmaceuticals NUVL Nuvalent CELC Celcuity LLC JANX Janux Therapeutics SMMT Summit Therapeutics PLC CGEM Cullinan Oncology LLC ORIC Oric Pharmaceuticals  PYXS Pyxis Oncology BP BP PLC ADR CGON CG Oncology, Common stock EXEL Exelixis GLTO Galecto  OLMA Olema Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Mar-2022

$4

$1.96 (96.08%)

6 months 4 days ago
(10-Mar-2026)

2/8 (25%)

$1.96 (96.08%)

203

Hold Since 01-Aug-2024

$1.5

$-0.54 (-26.47%)

$3

1 years 6 months 7 days ago
(07-Mar-2025)

3/8 (37.5%)

$0.44 (41.51%)

324

Buy Since 11-Aug-2020

$21

1 years 6 months 8 days ago
(06-Mar-2025)

3/9 (33.33%)

$12.33 (142.21%)

34

Hold Since 06-Mar-2025

$3

$0.96 (47.06%)

1 years 6 months 8 days ago
(06-Mar-2025)

1/5 (20%)

$1.69 (129.01%)

93

Buy Since 09-Aug-2022

1 years 7 months 21 days ago
(24-Jan-2025)

0/4 (0%)

$16.62 (260.50%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Bradley Canino most bullish on?

Potential upside of $4.79 has been obtained for PYXS (PYXIS ONCOLOGY)

Which stock is Bradley Canino most reserved on?

Potential downside of $1.96 has been obtained for ORIC (ORIC PHARMACEUTICALS )

What Year was the first public recommendation made by Bradley Canino?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?